Cretostimogene is an oncolytic immunotherapy with dual mechanism of action: viral replication leading to tumor lysis and release of granulocyte-macrophage colony stimulating factor.
Although the role of radiation therapy is well established in this setting, the role of radical prostatectomy in treating men with de novo oligometastatic prostate cancer has not been well defined.
More than 2 decades have passed since I became the first full-time editor of Renal & Urology News. During that time, the ...
The FDA expanded the approval of Pluvicto (lutetium Lu 177 vipivotide tetraxetan) to include patients with PSMA-positive mCRPC who have been treated with ARPI therapy and are considered appropriate to ...
The FDA has approved Imfinzi® (durvalumab), in combination with gemcitabine and cisplatin, for the treatment of adult patients with MIBC.
(HealthDay News) — A wearable T-shirt monitor can help oncological urology patients return home sooner after robotic-assisted surgery, according to a study presented at the 40th annual European ...
(HealthDay News) — Avoidable mortality is increasing in the United States and decreasing in comparator countries, according to a study published online March 24 in JAMA Internal Medicine.
A Chinese woman is the third person in the world living with a gene-edited pig kidney, and nearly 3 weeks after surgery, doctors say she’s doing well. The woman, reportedly 69 years old, had kidney ...
There is a high unmet need for effective neoadjuvant treatments for muscle-invasive bladder cancer for patients who cannot tolerate or refuse cisplatin chemotherapy.
For most patients, definitive treatment with combined modality therapy is recommended. (HealthDay News) — In a clinical practice guideline issued by the American Society for Radiation Oncology ...
Radiation-related bowel toxicity among real-world patients was lower with use of the rectal spacer. Use of a hydrogel rectal spacer reduces the incidence of bowel disorders and related procedures ...
Patients who continued Ozempic through total joint arthroplasty had the highest risk for complications. (HealthDay News) — Stopping glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment ...